Technical Breakout Stocks: How to trade Ajanta Pharma, BHEL and Hindustan Zinc on Monday?

Indian market witnessed profit-taking on Friday tracking muted global cues. The S&P BSE Sensex plunged more than 700 points while the Nifty50 closed below 22,500 levels.

Indian market witnessed profit-taking on Friday tracking muted global cues. The S&P BSE Sensex plunged more than 700 points while the Nifty50 closed below 22,500 levels.

Sectorally, buying was seen in metals, healthcare, and public sector while selling was seen in realty, capital goods and telecom indices which were down more than 1% each.

Stocks that were in focus include names like which was up more than 6%, closed with gains of more than 4% and closed with gains of more than 9% on Friday.

Analyst: Mitesh Karwa, Research Analyst at Bonanza Portfolio


Ajanta Pharma: Buy| Target Rs 2700| Stop Loss Rs 2250

Ajanta Pharma is seen to be opening with a big gap-up and breaking a resistance zone on the daily timeframe with above-average volumes and making a new all-time high on the daily timeframe which confirms the bullish view.

Buying can be initiated in Ajanta Pharma stock at current levels of around 2380-2383 with stoploss of 2250 and targets of 2700.
Ajanta PharmaETMarkets.com


BHEL: Book partial profits

BHEL LTD is seen to be achieving its technical target on the monthly timeframe and RSI is seen to be in an overbought zone which is why buying is not recommended at current levels.

Partial profit booking of current holding can be done at current levels as the stock might correct in the short term, although the longer-term trend is still sideways to bullish.
BHEL 3 MayETMarkets.com


Hindustan Zinc: Buy| Target Rs 540| Stop Loss Rs 370

Hindustan Zinc is seen to be breaking out of a bullish cup and handle-like formation on the monthly timeframe with a bullish candlestick and above-average volumes.

Buying can be done on dips of 420-430 with a stop loss below 370 and targets of 540.
Hindustan ZincETMarkets.com

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Chinese stocks hold bullish outlook, Gavekal Research says
24.09.2024 - 08:00
Levi Strauss warns of delay in hitting $10 billion sales goal, FT reports
24.09.2024 - 08:00
Oil firms evacuating US Gulf of Mexico staff as major hurricane looms
24.09.2024 - 07:00
Pro Research: Wall Street eyes Adobe's AI-driven growth
24.09.2024 - 06:00
Pro Research: Wall Street eyes Autodesk amid strategic shifts
24.09.2024 - 06:00
Pro Research: Wall Street dives into Apple's diverse prospects
24.09.2024 - 06:00
Asian stocks rise on China stimulus cheer; Australia lags before RBA
24.09.2024 - 06:00
Salesforce CTO Harris Parker sells shares worth over $249k
24.09.2024 - 05:00
Pro Research: Wall Street deep dive into Nike's market dynamics
24.09.2024 - 05:00
Avidity Biosciences CFO sells over $500k in company stock
24.09.2024 - 05:00
Salesforce executive sells over $1.5m in company stock
24.09.2024 - 05:00
American Eagle Outfitters exec chairman sells over $20 million in stock
24.09.2024 - 05:00
Avidity Biosciences executive sells over $1 million in company stock
24.09.2024 - 05:00
Salesforce executive sells over $17k in company stock
24.09.2024 - 05:00
Avidity Biosciences CEO sells over $1.4 million in company stock
24.09.2024 - 05:00

© Analytic DC. All Rights Reserved.

new
Огляд ринку Ділова активність у США у вересні залишилася стабільною, але ціновий тиск посилюється
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.